1Alemany R,Balague C,Curiel DT.Replicative adenoviruses for cancer therapy.Nat Biotechnol,2000,18:723-727.
2Kirn D,Martuza RL,Zweibel J.Replication-selective virotherapy for cancer:Biological principles,risk management and future direction.Nat Med,2001,7:781-787.
3Su CQ,Sham J,Xue HB,et al.Potent Antitumoral efficacy of a novel replicative adenovirus CNHK300 targeted to the telomerase-positve cancer cells.Accepted by J Cancer Res Clin Oncol,2004,12:56-65.
4Wirth T,Zender L,Schulte B,et al.A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.Cancer Res,2003,63:3181-3188.
5Huang TG,Savontaus MJ,Shinozaki K,et al.Telomerase-dependent oncolytic adenovirus for cancer treatment.Gene Ther,2003,10:1241-1247.
6Bischoff JR;Kim DH;Williams A.An adenovirus mutant that replicates selectively in p53-deficient human tumor cells[J],1996.
7Nemunaitis J;Gardy I;Khuri F.selective replication and oncolysis in p53 mutant tumors with ONXY-015, an E1B-55KD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase-Ⅱtrial,2000.
8Ries SJ;Brandts CH;Chung AS.Loss of p14ARF in tumor cells facilitates replication of the adnovirus mutant dl1520 ( ONYX-015 )[J],2000.
9Motoi F;Sunamura M;Ding L.Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus[J],2000(11).
